Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder of the Company, Johnfrancis Mathew Menezes (Folio No. 011661), received from Registrar and Transfer Agent, Link Intime India on February 18, 2023.
The above information is a part of company’s filings submitted to BSE.
